Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Bulletin Du Cancer
|
April 12, 2026
[Corrigendum to: "French recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2024-2025: Management of high-grade ovarian epithelial cancer" [Bull Cancer 2026;113:191-207]]
Frédéric Selle, Manuel Rodrigues, Benoît You, et al.
Bulletin Du Cancer
|
April 12, 2023
[Treatments for rare ovarian tumors: What's new?]
Coriolan Lebreton, Stanislas Quesada, Marta Bini, et al.
Bulletin Du Cancer
|
January 31, 2026
[French recommendations for clinical practice, Nice-Saint-Paul de Vence 2024-2025: Management of high-grade ovarian epithelial cancer]
Frédéric Selle, Manuel Rodrigues, Benoît You, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 4, 2024
Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world study
Jeannie M'Baloula, David Tougeron, Alice Boilève, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 18, 2024
Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics
Stanislas Quesada, Frédérique Penault-Llorca, Xavier Matias-Guiu, et al.
Journal of Personalized Medicine
|
October 27, 2022
Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial
Elise Bonnet, Véronique Haddad, Stanislas Quesada, et al.
Cancers
|
August 26, 2022
Real-World Data on Newly Diagnosed <i>BRCA</i>-Mutated High-Grade Epithelial Ovarian Cancers: The French National Multicenter ESME Database
Marta Bini, Stanislas Quesada, Pierre Meeus, et al.
JNCI Cancer Spectrum
|
December 14, 2024
Improving real-world evaluation of patient- and physician-reported tolerability: niraparib for recurrent ovarian cancer (NiQoLe)
Florence Joly, Fernando Bazan, Delphine Garbay, et al.
Lancet (London, England)
|
April 13, 2026
Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial
Domenica Lorusso, Laurence Gladieff, David M O'Malley, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Bulletin Du Cancer
|
April 12, 2026
[Corrigendum to: "French recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2024-2025: Management of high-grade ovarian epithelial cancer" [Bull Cancer 2026;113:191-207]]
Frédéric Selle, Manuel Rodrigues, Benoît You, et al.
Bulletin Du Cancer
|
April 12, 2023
[Treatments for rare ovarian tumors: What's new?]
Coriolan Lebreton, Stanislas Quesada, Marta Bini, et al.
Bulletin Du Cancer
|
January 31, 2026
[French recommendations for clinical practice, Nice-Saint-Paul de Vence 2024-2025: Management of high-grade ovarian epithelial cancer]
Frédéric Selle, Manuel Rodrigues, Benoît You, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 4, 2024
Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world study
Jeannie M'Baloula, David Tougeron, Alice Boilève, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 18, 2024
Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics
Stanislas Quesada, Frédérique Penault-Llorca, Xavier Matias-Guiu, et al.
Journal of Personalized Medicine
|
October 27, 2022
Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial
Elise Bonnet, Véronique Haddad, Stanislas Quesada, et al.
Cancers
|
August 26, 2022
Real-World Data on Newly Diagnosed <i>BRCA</i>-Mutated High-Grade Epithelial Ovarian Cancers: The French National Multicenter ESME Database
Marta Bini, Stanislas Quesada, Pierre Meeus, et al.
JNCI Cancer Spectrum
|
December 14, 2024
Improving real-world evaluation of patient- and physician-reported tolerability: niraparib for recurrent ovarian cancer (NiQoLe)
Florence Joly, Fernando Bazan, Delphine Garbay, et al.
Lancet (London, England)
|
April 13, 2026
Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial
Domenica Lorusso, Laurence Gladieff, David M O'Malley, et al.
Page
of 4